Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Singhal, Tarun
NCT04510220: 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis	Recruiting	3	10	US	Ofatumumab, OMB157, [F-18]PBR06, [18F]PBR06	Brigham and Women's Hospital, Novartis	Relapsing Multiple Sclerosis	12/21	12/21
NCT03983252: Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis	Not yet recruiting	1/2	10	US	[F-18]PBR06, [18F]PBR06	Brigham and Women's Hospital, Genzyme, a Sanofi Company	Multiple Sclerosis	05/24	05/24
Khuana, Vikram
No trials found
Pitaro, Ariana
No trials found
Khurana, Vikram
No trials found